<DOC>
	<DOCNO>NCT00116480</DOCNO>
	<brief_summary>Postpartum haemorrhage ( PPH ) remain leading cause maternal mortality , despite treatment conventional method . Uncontrolled report three small randomise controlled trial suggest misoprostol may additive effect routine treatment , serious danger method use widely without research document effectiveness risk method . In randomised control trial ( RCT ) , propose test whether 600 Î¼g sublingually administer misoprostol woman require additional uterotonics delivery , routine syntocinon woman delivery , additional effect additional conventional uterotonics reduce PPH . Women measure blood loss great equal 500 ml 4 Karachi hospital give consent give locally routine treatment PPH . In addition , enrol draw next series randomise treatment pack contain misoprostol placebo . The primary outcome measure blood loss great equal 500 ml enrolment .</brief_summary>
	<brief_title>Misoprostol Treatment Postpartum Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>All woman deliver vaginally clinically diagnose PPH require uterotonics Refusal give consent participation woman distress give consent Woman entitle give inform consent ( e.g . minor without guardian ) Woman caesarean section Delivery regard abortion ( gestational age &lt; 28 week )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Postpartum Haemorrhage</keyword>
	<keyword>Misoprostol</keyword>
</DOC>